相关实验视频
Updated: Jun 4, 2025
09:49
Isolation and Cannulation of Cerebral Parenchymal Arterioles
Published on: May 23, 2016
11.6K
托卢是一种通过BK通道作用的脑动脉收缩剂
Andrew A Shaw1, Jeffery D Steketee1, Anna N Bukiya1
1Department of Pharmacology, Addiction Science, and Toxicology, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN, 38103, USA.
Neuropharmacology
|December 20, 2024
概括
托卢的吸入会通过收缩中脑动脉 (MCA) 引起大脑的低 perfusion. 这项研究显示,烯直接抑制MCA光滑肌细胞中的BK通道,导致动脉收缩和潜在的急性脑毒性.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 心血管生理学心血管生理学
背景情况:
- 透过吸入的多卢滥用可以导致急性脑功能障碍和低.
- 托洛的急性神经毒性背后的精确机制,特别是它对大脑血流的影响,尚未完全理解.
- 托卢的急性毒性症状与脑缺血的症状重叠,表明血管参与.
研究的目的:
- 调查多对大脑动脉直径的直接影响,并确定潜在的分子标.
- 为了确定托卢是否会在与人类滥用相关的度下引起中脑动脉 (MCA) 的血管收缩.
- 阐明BK通道在烯诱导的MCA直径变化中的作用.
主要方法:
- 在暴露于托卢的老鼠和小鼠模型中,MCA直径的体内评估.
- 对压缩MCA进行了ex vivo研究,以评估烯的直接约束作用.
- 平滑肌细胞BK通道的电生理学记录 (补丁).
- 基因操纵 (KCNMA1删除) 和BK通道的药理封锁.
主要成果:
- 在雄性和雌性动物体内,托卢的吸入显著降低了MCA直径.
- 在度低于1毫米的情况下,托卢会导致MCA收缩,这与内皮无关.
- 托卢直接抑制了MCA光滑肌细胞中BK通道的活性,这种效果被KCNMA1删除或帕克西林阻塞所削弱.
结论:
- 托卢直接抑制MCA光滑肌细胞中的BK通道.
- 这种抑制导致MCA收缩,导致在急性二烯中毒中观察到的低 perfusion.
- 这些发现确定了二烯急性神经毒性作用的直接血管机制.
相关概念视频
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
405
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
405
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
455
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
455
01:23Antihypertensive Drugs: Vasodilators
474
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
474
01:23Local Anesthetics: Mechanism of Action
2.2K
Local anesthetics (LAs) block sensory and motor impulses by inhibiting the sodium channels on the nerve cell membranes. This induces temporary loss of sensation, relieving pain in a specific body area.
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
2.2K
01:28Antihypertensive Drugs: Types of β-Blockers
578
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
578
01:13Local Anesthetics: Pharmacokinetics
729
The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...
729